MapLight director awarded RSUs and stock options
MapLight Therapeutics, Inc. reported that director Nanna Liebach Luneborg received new equity awards as part of non-employee director compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
MapLight Therapeutics, Inc. reported that director Nanna Liebach Luneborg received new equity awards as part of non-employee director compensation. She was granted 3,932 restricted stock units, each representing one share of voting common stock, and a stock option for 14,902 shares at an exercise price of $28.64 per share.
Both the RSUs and the option were granted under the company’s 2025 Equity Incentive Plan and will vest on the earlier of June 23, 2027, or the date of the next annual stockholder meeting, subject to her continuous service.
Insider Trade Summary
Grant/Award: 18,834 shares
Grant/Award
2 txns
Insider
Luneborg Nanna Liebach
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 14,902 | $0.00 | $0.00 |
| Grant/Award | Voting Common Stock | 3,932 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 14,902 contracts (Direct);
Voting Common Stock — 3,932 shares (Direct)
Footnotes (3)
- F1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.
- F2. Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
- F3. Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.
Key Figures
RSUs granted: 3,932 units
Stock options granted: 14,902 shares
Option exercise price: $28.64 per share
+5 more
8 metrics
RSUs granted
3,932 units
Restricted stock units awarded to director on June 23, 2026
Stock options granted
14,902 shares
Option for voting common stock granted to director
Option exercise price
$28.64 per share
Exercise price for director’s stock option grant
Option expiration
June 22, 2036
Expiration date of director’s stock option grant
RSU vesting date
June 23, 2027 (or earlier meeting)
Vests on earlier of June 23, 2027 or next annual meeting
Option vesting date
June 23, 2027 (or earlier meeting)
Option vests on earlier of June 23, 2027 or next annual meeting
Shares after RSU grant
3,932 shares
Total voting common stock following RSU transaction
Options after grant
14,902 options
Total derivative position following option grant
Key Terms
restricted stock units ("RSUs"), 2025 Equity Incentive Plan, Continuous Service, non-employee director compensation policy, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
2025 Equity Incentive Plan financial
"Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan")"
Continuous Service financial
"subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date"
non-employee director compensation policy financial
"This grant was made pursuant to the Issuer's non-employee director compensation policy"
stock option financial
"Represents a stock option granted pursuant to the Plan"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MapLight Therapeutics (MPLT) report for Nanna Liebach Luneborg?
MapLight reported that director Nanna Liebach Luneborg received equity awards as compensation. She was granted 3,932 restricted stock units and a stock option for 14,902 shares, providing future rights to voting common stock if vesting and exercise conditions are met.
How many RSUs were granted to the MapLight (MPLT) director and what do they represent?
The director received 3,932 restricted stock units. Each RSU represents a contingent right to receive one share of MapLight’s voting common stock, delivering actual shares only when the vesting conditions and continuous service requirements under the 2025 Equity Incentive Plan are satisfied.
What are the key terms of the stock option granted to the MapLight (MPLT) director?
The director was granted a stock option covering 14,902 shares of voting common stock at an exercise price of $28.64 per share. The option expires on June 22, 2036, and vests based on continued board service through the specified vesting date.
When do the MapLight (MPLT) director’s RSUs and stock options vest?
Both the RSUs and the stock option vest on the earlier of June 23, 2027, or the date of MapLight’s next annual stockholder meeting. Vesting is conditioned on the director maintaining Continuous Service, as defined in the company’s 2025 Equity Incentive Plan.
Under which plan were the MapLight (MPLT) director’s equity awards granted?
The RSUs and stock option were granted under MapLight’s 2025 Equity Incentive Plan. The filing states that these awards were made pursuant to the company’s non-employee director compensation policy, aligning director pay with equity interests in the business.
Are the MapLight (MPLT) director’s equity awards part of a purchase or compensation grant?
The awards are compensation grants, not open-market purchases. The Form 4 labels both transactions with code A for grant or award, and the footnotes explain they were issued under the 2025 Equity Incentive Plan and non-employee director compensation policy, rather than being bought for cash.
AI-generated analysis. How Rhea-AI works. Not financial advice.
